| 注册
首页|期刊导航|世界中医药|临床研究中知情同意实施过程的要点及建议

临床研究中知情同意实施过程的要点及建议

柴倩云 费宇彤 王聪聪 夏芸 韩梅 刘建平

世界中医药Issue(10):1269-1271,3.
世界中医药Issue(10):1269-1271,3.DOI:10.3969/j.issn.1673-7202.2014.10.004

临床研究中知情同意实施过程的要点及建议

The key points and suggestions for implementing informed consent in clinical research

柴倩云 1费宇彤 1王聪聪 1夏芸 2韩梅 1刘建平1

作者信息

  • 1. 北京中医药大学循证医学中心,北京,100029
  • 2. 北京中医药大学东方医院科研处,北京,100078
  • 折叠

摘要

Abstract

With the widely development of Chinese medicine clinical research,the ethic issue has been gradually concerned.Although the ethical review has been implemented according to some rules,there are still many problems and challenges on proceeding informed consent.According to the relevant laws and regulations,this article incorporates the characteristics of Chinese medicine clinical research and the findings from an expert panel interview,to come up with some suggestions about how to proceed informed consent in Chinese clin-ical research.

关键词

知情同意/临床研究/伦理/中医药

Key words

Informed consent/Clinical study/TCM/Ethic

分类

医药卫生

引用本文复制引用

柴倩云,费宇彤,王聪聪,夏芸,韩梅,刘建平..临床研究中知情同意实施过程的要点及建议[J].世界中医药,2014,(10):1269-1271,3.

基金项目

国家自然科学基金(编号30901929);新世纪人才计划(NCET-10-0271);北京市科技新星项目(2011071);国家重大新药创制“临床评价研究标准化操作规程(SOP)”项目[编号2011ZX09302-006-01-03(5)] ()

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文